| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2016 | Meckler Jeffrey A45 | Director | Buy | 5,000 | $15.31 | $76,564.50 | +10.6% | |
| Mar 3, 2016 | Meckler Jeffrey A45 | Director | Buy | 10,000 | $14.45 | $144,500.00 | +27.0% | |
| Mar 1, 2016 | Shih Alvin | EVP Of Research &Development | Sell | 8,750 | $14.35 | $125,568.63 | -4.7% | |
| Dec 9, 2015 | Shih Alvin | EVP Of Research &Development | Sell | 8,750 | $20.83 | $182,262.50 | -4.5% | |
| Nov 10, 2015 | Aselage Steve80 | Chief Executive Officer | Sell | 60,000 | $18.75 | $1,124,700.00 | -8.5% | |
| Nov 2, 2015 | Valeur Jensen Margaret E | General Counsel | Sell | 50,000 | $20.46 | $1,022,948.64 | -32.2% | |
| Oct 6, 2015 | Shih Alvin | EVP Of Research &Development | Sell | 8,750 | $20.12 | $176,072.88 | -1.5% | |
| Jun 26, 2015 | Shih Alvin | EVP Of Research &Development | Sell | 27,916 | $32.70 | $912,850.41 | -12.1% |